Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-038922
Filing Date
2025-08-07
Accepted
2025-08-07 16:26:08
Documents
62
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q carm-20250630.htm   iXBRL 10-Q 887905
2 EX-31.1 carm-20250630xexx3111.htm EX-31.1 10513
3 EX-31.2 carm-20250630xexx3121.htm EX-31.2 10403
4 EX-32.1 carm-20250630xexx3211.htm EX-32.1 4908
5 EX-32.2 carm-20250630xexx3221.htm EX-32.2 4759
  Complete submission text file 0001628280-25-038922.txt   4919408

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT carm-20250630.xsd EX-101.SCH 41322
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT carm-20250630_cal.xml EX-101.CAL 64591
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT carm-20250630_def.xml EX-101.DEF 121966
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT carm-20250630_lab.xml EX-101.LAB 566364
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT carm-20250630_pre.xml EX-101.PRE 350003
65 EXTRACTED XBRL INSTANCE DOCUMENT carm-20250630_htm.xml XML 473566
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 251194536
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)